Characteristics and patient-reported outcomes of long-term lung cancer survivors

Ana Fonseca,Mariana Antunes,João Firmino-Machado,Ana Barroso,Margarida Dias

DOI: https://doi.org/10.21037/jtd-23-1494

2024-02-25

Journal of Thoracic Disease

Abstract:Characteristics and patient-reported outcomes of long-term lung cancer survivors

respiratory system

What problem does this paper attempt to address?

Factors Associated With Long Survival in Patients With Cancer Admitted to Palliative Care: An Exploratory Study

José António Ferraz-Gonçalves,Adelaide Alves,Álvaro José Silva,Ana Carmo Valente,Ana Pina,Áurea Lima,Daniela Antunes,Francisco Cubal,Isabel Costa,Jorge Rodrigues,Mariana Costa,Mariana Ramos,Michael Luis,Sofia Garcês Soares,Sofia Sousa,Teresa Dias Moreira,Vânia Sá-Araújo,Maria José Bento

DOI: https://doi.org/10.1177/08258597241231005

2024-02-21

Journal of Palliative Care

Abstract:Journal of Palliative Care, Ahead of Print. Objective: Some patients with cancer admitted to palliative care have relatively long survivals of 1 year or more. The objective of this study was to find out factors associated with prolonged survival. Methods: Retrospective case-control study comparing the available data of patients with cancer who survived more than 1 year after admission in a palliative care service with patients with cancer who survived 6 months or less. The intended proportion was 4 controls for each case. Patients were identified through electronic records from 2012 until 2018. Results: And 1721 patients were identified. Of those patients, 111 (6.4%) survived for at least 1 year, and 363 (21.1%) were included as controls according to the established criteria. The intended proportion could not be reached; the proportion was only 3.3:1. The median survival of cases was 581 days (range: 371-2763), and the median survival of controls was 57 days (range: 1-182). In the multivariable analysis, patients with a hemoglobin ≥ 10.6 g/dL and a creatinine level >95 μmol/L had a higher probability of living more than 1 year. In contrast, patients with abnormal cognition, pain, anorexia, liver metastases, an Eastern Cooperative Oncology Group performance status >1, and a neutrophil/lymphocyte ratio ≥ 3.43 had a low probability of living more than 1 year. Conclusion: Several factors were statistically associated positively or negatively with prolonged survival. However, the data of this study should be confirmed in other studies.

public, environmental & occupational health,health care sciences & services,health policy & services
Social determinants of health and patient reported outcomes in lung cancer survivors.

Yanmei Peng,Andrea L. Cheville,Jennifer Ridgeway,Roberto P. Benzo,Jason A. Wampfler,Claire I. Yee,Matthew Buras,Nathan Y Yu,Vinicius Ernani,Pedro A Reck dos Santos,Karen L. Swanson,Jonathan D'Cunha,Aminah Jatoi,Ping Yang

DOI: https://doi.org/10.1200/jco.2024.42.16_suppl.11118

IF: 45.3

2024-06-01

Journal of Clinical Oncology

Abstract:11118 Background: Lung cancer survivors experience more physical and mental challenges, heavier symptom burden, and poorer quality of life than survivors of other cancers. Many symptoms persist or worsen for survivors beyond 5 years of cancer diagnosis, referred as long-term lung cancer survivors (LTLCS). Social determinants of health (SDoH) factors negatively impact patient reported outcomes (PROs) among cancer survivors, but their role in outcomes is under reported in lung cancer survivors and unknown in LTLCS. We investigated the impact of SDoH on PROs in a 20-year prospective lung cancer cohort. Methods: Our cohort includes 19,251 lung cancer patients (cases) diagnosed from 1997 through 2016 and followed up to 27 years, of whom 4799 (25%) became LTLCS. SDoH information was obtained by a lung cancer study PRO questionnaire or an institution SDoH questionnaire. Analyzed in this report are 2982 cases and 480 controls who had a low-dose chest CT scan and were ruled out for cancer, all answered at least one PRO questionnaire (first response); and 1366 LTLCS answered 5 years after diagnosis (long-term response). Along with fatigue and dyspnea, 5 SDoH variables, i.e., financial concerns, legal concerns, family and friends support, spiritual well-being, and social activity were scored on a 0 (worst) - 10 (best) scale and dichotomized as 0-5 (deficit/worse/lower) or 6-10 (no deficit/better/higher). We also assessed employment and health-related work experience. A difference of 1.0 unit or more in score was considered clinically meaningful along with a 2-sided test P-value less than 0.05; Chi-square or Fisher’s Exact Test and Kruskal-Wallis test were used accordingly. Results: Compared to controls, cases were younger (mean age: 62 vs. 65 years, P<0.05); more women than men reported worse financial concerns (56% vs. 38%, P<0.01) and lower spiritual well-being (43% vs. 26%, P=0.04) at first response; this sex disparity reduced but remained significant at long-term. Worse dyspnea (4.4-4.8 vs. 5.6) and fatigue (4.7-4.8 vs. 5.8-5.9) were seen in cases with more financial and legal concerns compared to those with fewer concerns (Ps<0.01). Cases with higher family and friends support, spiritual well-being and social activity had less dyspnea (5.7-6.0 vs. 4.2-4.5) and fatigue (5.5-5.9 vs. 3.9-4.4) than those with lower scores (Ps<0.04). Employment and health-related work experience data were provided by 2213 responders: Comparing 1735 cases to 478 controls, a lower proportion of cases was employed (28% vs. 39%), more cases “often felt tired after work” (49% vs. 28%), and more cases had “quite a lot” of difficulty in daily work or could not work at all” (26% vs. 9%, Ps<0.01). Conclusions: We found that in lung cancer survivors, more women than men reported worse financial concerns, and lower SDoH status was correlated with worse dyspnea and fatigue, indicating SDoH-driven interventions are important to improve lung cancer survivors’ PROs.

oncology
Is it really over when it is over? physical, mental and emotional health status of long-term breast cancer survivors compared to healthy matched controls

Francisco Álvarez-Salvago,Palmira Gutiérrez-García,Cristina Molina-García,Sandra Atienzar-Aroca,José Daniel Jiménez-García,Agustín Aibar-Almazán,Antonio Martínez-Amat,Clara Pujol-Fuentes

DOI: https://doi.org/10.1007/s00520-024-08830-7

2024-09-07

Abstract:Purpose: This study aimed to assess pain, fitness condition, physical activity (PA) level, comorbidities, cancer-related fatigue (CRF), mood state and health-related quality of life (HRQoL) in long-term breast cancer survivors (LTBCS) compared to women without cancer history, matched by age, weight, height, and educational level. Methods: A cross-sectional study conducted in Granada between April 2018 and July 2023 involved 80 LTBCS and 80 matched controls. Pain, fitness condition, PA level, comorbidities, CRF, mood state, and HRQoL were evaluated ≥ 5 years post-diagnosis using validated instruments. Results: LTBCS, compared to the controls, reported significantly higher levels of "pain intensity and interference", CRF (in all domains and > 40% exhibited moderate-to-severe fatigue levels), "sadness-depression", "anxiety", "anger/hostility", and "symptom scales" (All: P = .000 to .027). Moreover, 66.25% of LTBCS not only did not reach recommended PA levels (P = .035), but also presented significantly lower levels of "general physical fitness", "muscular strength", "happiness", "functioning scales" (except "emotional functioning"), and "global health status" (All: P = .000 to .048). Conclusion: LTBCS still suffer from physical (pain, fitness condition, and CRF), both mental and emotional (sadness-depression, anxiety and anger/hostility) long-term side effects as well as multiple HRQoL issues (including lower levels of physical functioning and higher levels of symptoms). These findings highlight the chronic nature of this disease and the importance of continuing long- term follow-up care for survivors many years after the diagnosis of breast cancer.
Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study

Michael Jefford,Andrew C Ward,Karolina Lisy,Karen Lacey,Jon D Emery,Adam W Glaser,Hannah Cross,Mei Krishnasamy,Sue-Anne McLachlan,Jim Bishop

DOI: https://doi.org/10.1007/s00520-017-3725-5

IF: 3.1

2017-04-22

Supportive Care in Cancer

Abstract:PurposeThere is a lack of robust population-based data regarding the lived experience of cancer survivors. This study assessed the quality of life (QoL) of survivors of breast, colorectal, or prostate cancer, non-Hodgkin lymphoma or melanoma 1, 3 and 5 years post-diagnosis. Associations between various demographic and disease-related factors and QoL were assessed.MethodsA cross-sectional postal survey was undertaken. Eligible participants were identified from a population-based cancer registry. Patient-reported outcomes including QoL, symptom issues and information needs were collected using validated questionnaires.ResultsDifficulties with all QoL domains were more prevalent amongst cancer survivors compared with the general population, particularly difficulties with usual activities (28 vs 15%) and anxiety or depression (35 vs 22%). Symptoms such as trouble sleeping, always feeling tired, trouble concentrating and fear of cancer recurrence persisted up to 5 years post-diagnosis. Factors associated with reduced QoL included having another long-standing health condition, cancer not responding fully to treatment, not having or not being certain of having a written care plan and being female.ConclusionsCancer survivors experience inferior QoL and cancer-related symptoms for years following diagnosis. These results support further investigation into factors that contribute to poorer survivor outcomes and enhanced identification and intervention strategies for those requiring additional support.

oncology,health care sciences & services,rehabilitation
Comorbid conditions and health-related quality of life in long-term cancer survivors-associations with demographic and medical characteristics

Heide Götze,Sabine Taubenheim,Andreas Dietz,Florian Lordick,Anja Mehnert

DOI: https://doi.org/10.1007/s11764-018-0708-6

Abstract:Purpose: Our study provides a detailed overview of comorbid conditions and health-related quality of life of long-term cancer survivors and analyses the impact of demographic, disease- and treatment-related characteristics. Methods: We present data obtained from 1000 survivors across mixed tumour entities 5 and 10 years after cancer diagnosis in a cross-sectional study. We analyse the prevalence of physical symptoms and health conditions via self-report and health-related quality of life using the EORTC QLQ-C30 in comparison to gender- and age-matched reference values of the general population. Results: Cancer survivors reported on average 5 comorbidities; 23% had 7 or more comorbid conditions. Cancer survivors reported higher physical symptom burden than the population-especially fatigue, insomnia and pain. Type and prevalence of long-term and late effects differ with disease-related factors (e.g. cancer type, treatment) and characteristics of the patient. Cancer survivors also reported lower quality of life than the population, especially in everyday activities, social life, psychological well-being and financial difficulties. There was a positive association between high quality of life and a low level of morbidity. Conclusions: The specific knowledge about physical long-term consequences for the individual types of cancer could raise awareness in health care professionals for high-risk patients and help to develop adequate prevention and survivorship-programs. Implications for cancer survivors: Limitations in the mental health area underlines the importance of psycho-oncological survivorship-care-plans, which go beyond the time of rehabilitation. Special attention should be given to the financial situation of patients in long-term follow-up care.
Long-Term Follow-Up Care for Childhood Cancer Survivors

Jiaoyang Cai,Sara Malone,Nickhill Bhakta,Ching-Hon Pui,Jing Chen,Shaoyan Hu,Hui Jiang,Xiuli Ju,Fen Zhou,Melissa M. Hudson,Yin Ting Cheung

DOI: https://doi.org/10.1001/jamanetworkopen.2024.40258

2024-10-18

JAMA Network Open

Abstract:This survey study examines the perceptions of clinicians and caregivers regarding accessibility of and adherence to long-term follow-up care for childhood cancer survivors in China.

medicine, general & internal
Characteristics and patient-reported outcomes of long-term cancer survivors after apatinib-based therapy: an online survey

Tingting Zhang,Chao Meng,Wei He,Tao Xu,Yi Yang,Chongqi Tu,Ling Zhang,Xiaofeng Sun,Chunrong Zhu,Xueyi Dang,Ke Wang,Chuan Chen,Xiong Yan,Huiting Xu,Le Huang,Enlai Jiang,Feng Xia,Xinming Zhou,Shunkai Zhou,Weidong Zang,Xifeng Li,Jin Zhang,Jiaping Zheng,Jianjun Xin,Bin Huang,Guopei Zhu,Jiexiang Zhu,Jun Liang

DOI: https://doi.org/10.1186/s12885-024-12832-3

IF: 4.638

2024-08-31

BMC Cancer

Abstract:Background: Data on long-term cancer survivors treated with apatinib are lacking. This study aimed to describe the characteristics of long-term cancer survivors after apatinib-based therapy, and to know about their satisfaction degree with apatinib and severity of depression and insomnia. Methods: Patients with solid tumors who had received apatinib-based therapy for at least 5 years were invited to complete an online questionnaire. Characteristics of patients and treatment, knowledge of apatinib, satisfaction degree, and severity of depression and insomnia assessed by Patient Health Questionnaire-9 and Insomnia Severity Index were collected. Results: Between December 8, 2023 and March 1, 2024, a total of 436 patients completed the online questionnaire. Most patients were satisfied with the efficacy (96.6%) and safety (93.1%) of apatinib, were willing to continue apatinib treatment (99.5%), and would recommend apatinib to other patients (93.3%). Continuous apatinib treatment resulted in significant negative impact on daily life, work, or study in only two (0.5%) patients. Almost all patients currently had no or mild depression (97.0%) and insomnia (97.9%) problems. The most common patient-reported adverse events were hand-foot syndrome (21.3%) and hypertension (18.3%). Conclusions: Our survey showed a high satisfaction degree with apatinib in long-term cancer survivors. Long-term apatinib treatment resulted in almost no negative impact on patient's quality of life.
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC

William Tompkins,Connor B Grady,Wei-Ting Hwang,Krishna Chandrasekhara,Caroline McCoach,Fangdi Sun,Geoffrey Liu,Devalben Patel,Jorge Nieva,Amanda Herrmann,Kristen Marrone,Vincent K Lam,Vamsi Velcheti,Stephen V Liu,Gabriela Liliana Bravo Montenegro,Tejas Patil,Jared Weiss,Kelsey Leigh Miller,William Schwartzman,Jonathan E Dowell,Khvaramze Shaverdashvili,Liza Villaruz,Amanda Cass,Wade Iams,Dara Aisner,Charu Aggarwal,D Ross Camidge,Melina E Marmarelis,Lova Sun

DOI: https://doi.org/10.1016/j.jtocrr.2024.100669

2024-03-26

Abstract:Introduction: Characteristics of long-term survivors in EGFR-mutant (EGFRm) NSCLC are not fully understood. This retrospective analysis evaluated a multi-institution cohort of patients with EGFRm NSCLC treated in the pre-osimertinib era and sought to describe characteristics of long-term survivors. Methods: Clinical characteristics and outcomes were abstracted from the electronic medical records of patients with EGFRm metastatic NSCLC who started first-line therapy before 2015. Demographics and comutations were compared between greater than or equal to 5-year survivors and less than 5-year survivors. Multivariable Cox proportional hazard and logistic regression models were used to evaluate factors associated with survival and the odds of death within 5 years, respectively. Results: Overall, 133 patients were greater than or equal to 5-year survivors; 127 were less than 5-year survivors. Burden of pathogenic comutations including TP53 and PIK3CA was similar between greater than or equal to 5-year survivors and less than 5-year survivors. Receipt of first-line chemotherapy rather than EGFR tyrosine kinase inhibitor was similar between the groups (22% of <5-y versus 31% of ≥5-y). Baseline brain metastasis and history of smoking were associated with higher odds of death within 5 years (odds ratio = 2.16, p = 0.029 and odds ratio = 1.90, p = 0.046, respectively). Among patients without baseline brain metastases, cumulative incidence of brain metastases at 5 years was 42.3%. Both baseline and post-baseline brain metastasis were associated with worse overall survival compared with no brain metastasis (hazard ratio = 3.26, p < 0.001 and hazard ratio = 4.99, p < 0.001, respectively). Conclusions: Within patients treated for EGFRm metastatic NSCLC before 2015, absence of brain metastasis and nonsmoking status were predictive of 5-year survival. Our findings help to define a subset of patients with EGFRm NSCLC with excellent survival outcomes who may not require intensification of initial therapy.
Use of Survivorship Care Plans and Analysis of Patient-Reported Outcomes in Multinational Patients With Lung Cancer

Abigail T Berman,Cristina M DeCesaris,Charles B Simone 2nd,Carolyn Vachani,Gloria DiLullo,Margaret K Hampshire,James Metz,Christine Hill-Kayser

DOI: https://doi.org/10.1200/JOP.2015.008904

Abstract:Purpose: Lung cancer is the leading cause of cancer death and is a significant source of morbidity. Patient-reported outcomes (PROs) have been shown to be prognostic for survival. We have analyzed emerging patterns of longitudinal PROs collected in the development of survivorship care plans (SCPs). Methods: OncoLife and the LIVESTRONG Care Plans are Internet-based programs designed to generate unique SCPs. We selected SCPs from patients identifying as survivors of primary lung cancer. Patient-reported demographics and treatment and toxicity data were examined. Effects were categorized by the physiologic system that they affected. Results: Six hundred eighty-nine plans were created for users self-identifying as survivors of primary lung cancer. Average time from diagnosis to reporting was 1.68 years (range, 0 to 24 years). Most were white (85.9%), well educated (61.1% "some college" or higher), and lived in the United States (90.7%). Patients underwent chemotherapy (75.8%), radiotherapy (54.7%), and surgery (54.4%). Neurocognitive symptoms (eg, fatigue, cognitive changes) were the most common (48.8%), especially among those receiving chemotherapy, followed by musculoskeletal/dermatologic symptoms (14.1%) and thoracic symptoms (13.5%). Only 11.2% were initially offered an SCP. Of those offered SCPs, 54.5% were offered by their health care provider, and most often were at a non-university-based cancer center (66.2%). Conclusion: For patients with lung cancer worldwide, it is feasible to obtain PROs and to create SCPs through an Internet-based program. As patients with lung cancer achieve improved survival, further attention should be paid to PROs. Surprisingly, neurocognitive symptoms seem to be the most common issues and therefore the most important to address. Increased effort should be made to provide SCPs, particularly in urban and university cancer center settings.
Late effects, long‐term problems and unmet needs of cancer survivors

Martina E Schmidt,Siri Goldschmidt,Silke Hermann,Karen Steindorf

DOI: https://doi.org/10.1002/ijc.34152

2022-06-05

International Journal of Cancer

Abstract:Great efforts are being made in cancer treatment, with impressive improvement in survival. The situation concerning research and care for long‐term problems and late effects in the growing population of cancer survivors, however, is unsatisfactory. Therefore, in the FiX survey 1,348 disease‐free survivors about 4 years after diagnosis of different cancer types were asked to rate existing burdens and support received for them along a list of 36 potential problems. Health‐related quality of life (HRQoL) was assessed with the EORTC QLQ‐C30. Determinants of burdens were explored using logistic regression analysis. While cancer survivors' global HRQoL, physical and role function ratings were comparable or better than age‐ and sex‐matched reference values of the general population, emotional and cognitive function was worse, especially among women (p

oncology
Predictors of persistence of post-chemotherapy symptoms among survivors of solid tumor cancers

Alla Sikorskii,Terry Badger,Chris Segrin,Tracy E. Crane,Nathan Cunicelli,Pavani Chalasani,Waqas Arslan,Charles Given

DOI: https://doi.org/10.1007/s11136-023-03595-8

2024-01-31

Quality of Life Research

Abstract:Late or residual symptoms diminish quality of life for many cancer survivors after completion of treatment.

public, environmental & occupational health,health care sciences & services,health policy & services
Health-Related Quality of Life in Long-Term Colorectal Cancer Survivors

Alba Marcos-Delgado,Vicente Martín-Sánchez,Ana Molina-Barceló,Jessica Alonso-Molero,Beatriz Pérez-Gómez,Marina Pollán,Nuria Aragonés,María Ederra-Sanza,Guillermo Fernández-Tardón,Gemma Binefa,Victor Moreno,Rocío Barrios-Rodríguez,Pilar Amiano,José María Huerta,Enrique Pastor Teso,Juan Alguacil,Gemma Castaño-Vinyals,Manolis Kogevinas,Antonio José Molina de la Torre

DOI: https://doi.org/10.3390/healthcare12191917

2024-09-25

Health Care

Abstract:The aim of our study is to evaluate the relationship between sociodemographic and clinical characteristics of individuals with Colorectal Cancer (CRC), tumour-intrinsic characteristics and treatment received with health-related quality of life (HRQoL). Methods: Cross-sectional analysis of data from 805 survivors from the MCC study was conducted. HRQoL was assessed through a general and specific questionnaire, SF-12 and FCSI (Colorectal Symptom Index). Statistical analyses were performed with linear regression with adjustment for sociodemographic variables, stage at diagnosis and histological grade. Results: Participants had survived a median of 7.9 years from diagnosis (IQR 7.1–8.5 years). Age at diagnosis, sex and area showed a clear association with HRQoL in both physical and mental dimensions of the SF-12 questionnaire. A direct association between CRC recurrence was also found in the PCS-12 and MCS-12 dimensions and radical surgery in the PCS-12. Regarding the scores in FCSI questionnaire, statistically significant differences were observed by sex, age and area, with older women being the most impaired (p < 0.001). Conclusions: Age, sex and area was associated with lower scores of HRQoL among CRC survivors. Knowing the determinants related to HRQoL would allow us to lay the groundwork to develop strategies that help reduce morbidity and mortality, relapses and increase HRQoL.

health care sciences & services,health policy & services
Long‐term patient‐reported values following cancer surgery: A global survey study

Edward A. Joseph,Abiha Abdullah,Conor M. Maxwell,Samuel Yellin,Sricharan Chalikonda,David L. Bartlett,Casey J. Allen

DOI: https://doi.org/10.1002/jso.27788

2024-08-22

Journal of Surgical Oncology

Abstract:Background and Objectives We evaluated the long‐term quality of life (QOL) and priorities of an international cohort of cancer surgery survivors. Methods Patients were surveyed through online support groups. We utilized the Short Form‐12 questionnaire to evaluate QOL and a novel survey to assess the relative importance of longevity, experience, and costs. Results A total of 592 patients from six continents responded. They were 58 ± 12 years old, 70% female, and 92% White. Patients averaged 37 months from their initial cancer diagnosis, with a maximum survivorship of 46 years. Across 17 disease sites, respondents generally ranked longevity, functional independence, and emotional well‐being most important, while treatment experience and costs were ranked least important (W = 33.6%, p

oncology,surgery
Factors associated with patient-reported subjective well-being among advanced lung or non-colonic gastrointestinal cancer patients

Sriram Yennurajalingam,Yu Jung Kim,Yi Zhang,Jichan Park,Joseph Arthur,Gary B Chisholm,Janet L Williams,Eduardo Bruera

DOI: https://doi.org/10.1017/S1478951517000116

Abstract:Objective: The aim of this study was to determine the factors associated with a feeling of well-being using the Edmonton Symptom Assessment Scale (ESAS)-Feeling of Well-Being item (ESAS-FWB; where 0 = best and 10 = worst) among advanced lung or non-colonic gastrointestinal cancer patients who were referred to an outpatient palliative care clinic (OPCC). We also examined the association of performance on the ESAS-FWB with overall survival (OS). Method: We reviewed the records of consecutive patients with incurable advanced lung cancer and non-colonic gastrointestinal cancer presenting to an OPCC from 1 January 2008 through to 31 December 2013. Descriptive statistics were employed to summarize patient characteristics. Multivariate regression analysis was used to determine the factors associated with ESAS-FWB severity. We also examined the association of ESAS-FWB scores and survival using Kaplan-Meier survival analysis. Results: A total of 826 evaluable patients were analyzed (median age = 62 years, 57% male). Median ESAS-FWB scores were five times the interquartile range (5 × IQR; 3-7). ESAS-FWB score was found to be significantly associated with ESAS fatigue (OR = 2.31, p < 0.001); anxiety (OR = 1.98, p < 0.001); anorexia (OR = 2.31, p < 0.001); cut down, annoyed, guilty, eye opener (CAGE) score (hazard ratio [HR] = 1.80, p = 0.008); and family caregiver distress (HR = 1.93, p = 0.002). A worse ESAS-FWB score was significantly associated with decreased OS (r = -0.18, p < 0.001). However, ESAS-FWB score was not independently associated with OS in the final multivariate model (p = 0.35), which included known major clinical prognostic factors. Conclusions: Worse ESAS-FWB scores were significantly associated with high scores on ESAS fatigue, anorexia, anxiety, CAGE, and family caregiver distress. More research is necessary to understand how palliative care interventions are capable of improving the contributory factors related to ESAS-FWB score.
Long-term survival and functional outcomes of critically ill patients with hematologic malignancies: a Canadian multicenter prospective study

Laveena Munshi,Guillaume Dumas,Bram Rochwerg,Farah Shoukat,Michael Detsky,Dean A. Fergusson,Bruno L. Ferreyro,Paul Heffernan,Margaret Herridge,Sheldon Magder,Mark Minden,Rakesh Patel,Salman Qureshi,Aaron Schimmer,Santhosh Thyagu,Han Ting Wang,Sangeeta Mehta

DOI: https://doi.org/10.1007/s00134-024-07349-z

IF: 38.9

2024-03-12

Intensive Care Medicine

Abstract:Patients with hematologic malignancy (HM) commonly develop critical illness. Their long-term survival and functional outcomes have not been well described.

critical care medicine
Patient-Reported Outcomes 10 Years After Breast-Conserving Surgery for Early-Stage Breast Cancer

Laura S Dominici,Alison Laws,Mirelle Lagendijk,Samantha Grossmith,Melissa Hughes,Nancy Lin,Elizabeth A Mittendorf,Tari A King

DOI: https://doi.org/10.1245/s10434-024-15876-8

Abstract:Background: Patient-reported outcomes (PROs) are a critical component of value-based care. Limited data exist describing long-term PROs in patients undergoing breast-conserving surgery (BCS). Patients and methods: Patients undergoing surgery for stage 0-III breast cancer at our institution from 2002 to 2012 who agreed to be contacted were invited to participate in a cross-sectional PRO study. Health-related quality of life outcomes using BREAST-Q, EORTC QLQ-C30, and EORTC QLQ-BR45 were collected. Patients reporting chemotherapy within 6 months of receiving the survey were excluded. For this work, we focused on patients who underwent BCS. Multivariable linear regression was performed to identify factors associated with PRO scores, adjusting for age, time since surgery, anatomic stage, molecular subtype, receipt of systemic and/or radiation therapy (RT), locoregional recurrence, or contralateral breast cancer. Results: Among 562 interested and eligible patients, 437 (78%) responded; median time from surgery to survey completion was 10.4 years (interquartile range: 8.0-13.5). Median age at surgery was 53 years (standard deviation 9.8 years), ≥ 90% were white, had upfront surgery for early-stage disease, and completed adjuvant RT. Physical and psychological well-being scores were generally high, with more variation seen for sexual well-being and satisfaction with breasts. Conclusion: This study provides long-term PRO data for patients treated with BCS, demonstrating the ongoing association of breast cancer surgery with quality of life in the survivorship period and highlighting the importance of examining PROs beyond the perioperative period. These data also provide important reference values for the interpretation of PROs among women treated with BCS as we move towards value-based care.
Analysis of Factors Related to Physical Activity Levels Among Lung Cancer Survivors Who Underwent Nonsurgical Treatment: A Cross‐Sectional Study

Qiaoqiao Ma,Jing Luo,Xiaoqing Liu,Huxing Cao,Shengchang Ye,Nan Dang,Ting Wang,Jianfei Li,Shajing Fan,Lili Hou

DOI: https://doi.org/10.1111/jocn.17445

2024-09-21

Journal of Clinical Nursing

Abstract:Aim(s) The study aimed to investigate the current status of physical activity (PA) levels and associated factors among lung cancer survivors who have undergone nonsurgical treatments. Background PA has been incorporated as a nonpharmacological intervention in the rehabilitation programmes of cancer patients, playing a crucial role in alleviating symptom burden and enhancing the quality of life among lung cancer survivors. Understanding the potential influencing factors of PA levels aids in formulating targeted intervention strategies. Design A multicentre cross‐sectional study. Methods Convenience sampling was utilised to survey lung cancer survivors from the respiratory and oncology departments of 12 hospitals across Eastern, Central and Western China, spanning from June 2023 to January 2024. Social demographic characteristics, disease‐related features, health behaviour abilities, psychological factors and levels of PA were collected through a combination of clinical case systems used to record patients' treatment and medical conditions and self‐reported questionnaires. Additionally, measurements of grip strength and the 6‐min walk test were conducted for patients. Descriptive analysis, bivariate analysis and multivariate logistic regression were conducted. Results Only 109 patients (16.2%) achieved high PA levels. Multivariate logistic regression analysis indicated differences in age, residential location, employment status, religion, lung cancer stage, grip strength, albumin concentration, blood urea, Anderson symptom, depression and health behaviour capacity among lung cancer survivors with varying PA levels. Conclusions Significant associations were observed between age ≥ 75 years, residing in urban areas, unemployment, absence of religious beliefs, Stage IV lung cancer, lower grip strength, lower albumin concentration, higher blood urea, higher Anderson symptom scores, lower health behaviour capacity scores, higher depression scores and lower PA levels among lung cancer survivors. These potential factors should be considered when developing PA intervention plans. Relevance to Clinical Practice This study offers insights for developing subsequent PA intervention programmes. In clinical practice, healthcare professionals should continuously educate patients about the benefits of exercise and help them incorporate PA into their daily lives. Additionally, emphasising multidisciplinary collaboration involving physical therapists, nutritionists and mental health experts is crucial for ensuring safe and effective PA, thereby improving patients' quality of life. Reporting Method Our study complies with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Checklist: cross‐sectional studies. Patient or Public Contribution At the phase of collecting data, participants were recruited to fill the questionnaires. Trial Registration Chinese Clinical Trial Registry: ChiCTR2300072609

nursing
What patients with advanced cancer experience as helpful in navigating their life with a long-term response: a qualitative study

Laura C. Zwanenburg,Marije L. van der Lee,José J. Koldenhof,Karijn P. M. Suijkerbuijk,Melanie P. J. Schellekens

DOI: https://doi.org/10.1007/s00520-024-08398-2

IF: 3.1

2024-03-13

Supportive Care in Cancer

Abstract:Despite improved survival for people with advanced cancer due to new medical treatments, a growing group of long-term responders (LTRs) has to learn to live with uncertainties that affect several life domains. At the core of their experience, they neither feel like a patient nor feel healthy. Despite growing awareness of LTRs' experiences, learning more about how they cope with their long-term response can provide insight into how to best support them. Our study aimed to gain a deeper understanding what LTRs experience as helpful in navigating life with a long-term response.

oncology,health care sciences & services,rehabilitation
What Characterizes Long-term Survivors of Recurrent Ovarian Cancer? Case Report and Review of the Literature

Ziad Hilal,Beate Schultheis,Franziska Hartmann,Askin Dogan,Cem Cetin,Harald Krentel,Sven Schiermeier,Clemens B Tempfer

DOI: https://doi.org/10.21873/anticanres.11110

Abstract:Background: Women with recurrent ovarian cancer have a poor prognosis and short survival. However, some women are long-term survivors and it is unclear whether they share specific common characteristics. Case report: We present the case of a 63-year-old woman with histologically-proven recurrent ovarian cancer and a survival time of 16 years after the diagnosis of recurrence. She underwent initial debulking surgery in 1994, followed by 6 cycles of adjuvant chemotherapy with cisplatin and paclitaxel. After recurrent disease was diagnosed by re-laparotomy in 2000, she underwent four lines of systemic chemotherapy from 2000 to 2009 (carboplatin/paclitaxel, topotecan, etoposide/treosulfan and liposomal doxorubicin) and four lines of endocrine therapy between 2002 and 2014 (tamoxifen, goserelin, tamoxifen and exemestane). In 2014, she underwent secondary debulking surgery and was tumor-free until 2015. Upon progression, she was then started on the fifth-line of endocrine therapy, fulvestrant, which was changed to the mTOR inhibitor everolimus in June 2016. In a PUBMED literature search, 360 cases of long-term survivors of recurrent ovarian cancer (LTSROC), defined as women with survival >5 years after the diagnosis of recurrence, were identified with a mean post-recurrence survival time of 7.5 years. Comparing the patient and therapy details of these women, we identified common characteristics of LTSROC, i.e. young age and optimal debulking at initial surgery, a long time span between first-line therapy and first recurrence and the combined use of optimal cytoreductive surgery and systemic chemotherapy. Conclusion: LTSROC are rare, with 360 cases described in the literature. LTSROC are characterized by young age, low tumor stage, long recurrence-free interval and combined modality treatment with optimal cytoreductive surgery and systemic chemotherapy.
Assessing patient perception and preferences for outcomes in lung cancer resection surgery: a cross-sectional study

Matthew Shiu Hang Wong,Aina Pons,Paulo De Sousa,Chiara Proli,Simon Jordan,Sofina Begum,Silviu Buderi,Eric Lim

DOI: https://doi.org/10.21037/jtd-23-1800

2024-06-30

Abstract:Background: Surgical resection is the primary treatment for early-stage lung cancer, but little is known about the outcomes that truly matter to patients. This aim of our study was to identify the aspects of postoperative outcomes that matter most to patients undergoing lung cancer surgery and explore the influence of clinical and demographic factors on their importance ratings. Methods: We performed a cross-sectional study of patients undergoing lung resection for non-small cell lung cancer at our institution from November 2021 to May 2022. Patients were surveyed using a self-developed questionnaire and the European Organisation for Research and Treatment of Cancer core health-related quality of life questionnaire (EORTC QLQ-C30) prior to surgery. Ordinal logistic regression was performed to determine associations between individual patient factors and outcome importance ratings. Results: Forty patients completed the survey during the study period. Patients prioritized oncologic outcomes, with 95% rating R0 resection and cancer recurrence as "very important". Other important factors included overall survival (90%), postoperative complications (e.g., myocardial infarction: 92.5%, infection: 87.5%), and the need for reoperation (82.5%). Health-related quality of life factors, such as chronic pain (77.5%) and the ability to return to normal physical and exercise levels (75%), were also highly valued. Certain patient clinical and demographic factors demonstrated significant associations with importance placed on certain outcomes. Preoperative health-related quality of life scores did not influence outcome importance ratings. Conclusions: This study provides insights into the outcomes that matter most to patients undergoing lung cancer surgery. Oncologic outcomes and postoperative complications were prioritized, while scar-related factors were less important. Patient preferences varied based on demographic and clinical factors. Understanding these preferences can enhance shared decision-making and improve patient-centered care in thoracic surgical oncology.

Characteristics and patient-reported outcomes of long-term lung cancer survivors

Factors Associated With Long Survival in Patients With Cancer Admitted to Palliative Care: An Exploratory Study

Social determinants of health and patient reported outcomes in lung cancer survivors.

Is it really over when it is over? physical, mental and emotional health status of long-term breast cancer survivors compared to healthy matched controls

Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study

Comorbid conditions and health-related quality of life in long-term cancer survivors-associations with demographic and medical characteristics

Long-Term Follow-Up Care for Childhood Cancer Survivors

Characteristics and patient-reported outcomes of long-term cancer survivors after apatinib-based therapy: an online survey

Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC

Use of Survivorship Care Plans and Analysis of Patient-Reported Outcomes in Multinational Patients With Lung Cancer

Late effects, long‐term problems and unmet needs of cancer survivors

Predictors of persistence of post-chemotherapy symptoms among survivors of solid tumor cancers

Health-Related Quality of Life in Long-Term Colorectal Cancer Survivors

Long‐term patient‐reported values following cancer surgery: A global survey study

Factors associated with patient-reported subjective well-being among advanced lung or non-colonic gastrointestinal cancer patients

Long-term survival and functional outcomes of critically ill patients with hematologic malignancies: a Canadian multicenter prospective study

Patient-Reported Outcomes 10 Years After Breast-Conserving Surgery for Early-Stage Breast Cancer

Analysis of Factors Related to Physical Activity Levels Among Lung Cancer Survivors Who Underwent Nonsurgical Treatment: A Cross‐Sectional Study

What patients with advanced cancer experience as helpful in navigating their life with a long-term response: a qualitative study

What Characterizes Long-term Survivors of Recurrent Ovarian Cancer? Case Report and Review of the Literature

Assessing patient perception and preferences for outcomes in lung cancer resection surgery: a cross-sectional study